Faeth Therapeutics FTH
NASDAQ FTH
$20.71 +0.14 (+0.68%)
As of: Oct 22, 2026 · 1:56 PM EDT

Faeth Therapeutics (FTH) Cash & Equivalents (2020 - 2026)

Updated

Faeth Therapeutics (FTH) reported Cash & Equivalents of $26.9 million for Q2 2026, up 114.2% from $12.56 million a year earlier but down 82.3% from the prior quarter.

Analysis

Faeth Therapeutics (FTH) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Faeth Therapeutics posted Cash & Equivalents of $8.67 million, down 13.3% from FY2024.

  • Cash & Equivalents has declined for three consecutive years, with a five-year compound annual growth rate of -12.2% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $9.99 million in FY2024 (-23.2%), $13.01 million in FY2023 (-26.9%), $17.8 million in FY2022 (+148.6%) and $7.16 million in FY2021 (-56.9%).
  • Five-year quarterly Cash & Equivalents spans a low of $7.16 million in Q4 2021 and a high of $152.33 million in Q1 2026.
  • Year over year, Cash & Equivalents gained in three of the last seven quarters, with growth averaging 13.9%.
  • The high point for year-over-year Cash & Equivalents in five years was Q4 2022 (growth of 148.6%); the low point was Q1 2022 (a decline of 94.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $152.33 million (Q1 2026), $8.67 million (Q4 2025) and $10.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,170.64 Bn 1,139.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 647.91 Bn 567.77 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.02 Bn 476.13 Bn 12.70 Bn 6.57 Bn
4 Merck 365.11 Bn 319.49 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 303.38 Bn 267.37 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 268.87 Bn 242.56 Bn 12.86 Bn 4.90 Bn
7 Amgen 242.01 Bn 197.41 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.74 Bn 168.94 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 976.00 Mn
10 Faeth Therapeutics 116.87 Mn -318.59 Mn - 26.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.90 Mn
Mar 31, 2026 152.33 Mn
Dec 31, 2025 8.67 Mn
Sep 30, 2025 10.56 Mn
Jun 30, 2025 12.56 Mn
Mar 31, 2025 9.88 Mn
Dec 31, 2024 9.99 Mn
Sep 30, 2024 19.13 Mn
Jun 30, 2024 11.89 Mn
Mar 31, 2024 10.96 Mn
Dec 31, 2023 13.01 Mn
Sep 30, 2023 11.34 Mn
Jun 30, 2023 10.23 Mn
Mar 31, 2023 8.11 Mn
Dec 31, 2022 17.80 Mn
Sep 30, 2022 11.45 Mn
Jun 30, 2022 9.90 Mn
Mar 31, 2022 8.72 Mn
Dec 31, 2021 7.16 Mn
Sep 30, 2021 9.53 Mn
API Access

Faeth Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FTH&period=max&api_key=YOUR_API_KEY